Free Trial

iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving Average - Should You Sell?

iCAD logo with Computer and Technology background

iCAD, Inc. (NASDAQ:ICAD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.61 and traded as high as $2.06. iCAD shares last traded at $1.96, with a volume of 197,827 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised iCAD from a "sell" rating to a "hold" rating in a report on Thursday, November 21st.

Read Our Latest Research Report on iCAD

iCAD Price Performance

The firm has a market cap of $50.43 million, a PE ratio of -14.62 and a beta of 1.40. The company has a 50 day simple moving average of $1.83 and a 200-day simple moving average of $1.61.

Hedge Funds Weigh In On iCAD

A hedge fund recently bought a new stake in iCAD stock. Essex LLC bought a new position in shares of iCAD, Inc. (NASDAQ:ICAD - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 137,963 shares of the technology company's stock, valued at approximately $216,000. Essex LLC owned 0.52% of iCAD at the end of the most recent quarter. Institutional investors and hedge funds own 24.61% of the company's stock.

iCAD Company Profile

(Get Free Report)

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.

Read More

Should You Invest $1,000 in iCAD Right Now?

Before you consider iCAD, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iCAD wasn't on the list.

While iCAD currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines